Unique ID issued by UMIN | UMIN000007855 |
---|---|
Receipt number | R000009140 |
Scientific Title | Study for the add-on effect of vitamin K to Sorafenib treatment for hepatocellular carcinoma |
Date of disclosure of the study information | 2012/04/28 |
Last modified on | 2012/04/28 11:33:40 |
Study for the add-on effect of vitamin K to Sorafenib treatment for hepatocellular carcinoma
Sorafenib + vitamin K therapy for HCC
Study for the add-on effect of vitamin K to Sorafenib treatment for hepatocellular carcinoma
Sorafenib + vitamin K therapy for HCC
Japan |
hepatocellular carcinoma
Hepato-biliary-pancreatic medicine |
Malignancy
NO
Evaluation of the add-on effect of vitamin K to sorafenib treatment for hepatocellular carcinoma
Safety
Exploratory
Effect for overall survival
Evaluation of safety
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
2
Treatment
Medicine |
Srafenib + vitamin K combination therapy
Sorafenib monotherapy
18 | years-old | <= |
85 | years-old | > |
Male and Female
Patients with chronic hepatitis or compensated liver cirrhosis (Child-Pugh classification A), who do not have indication for either surgical resection nor radio frequency ablation or percutaneous ethanol infusion
Patients with uncontrollable infection
100
1st name | |
Middle name | |
Last name | Yoshimichi Haruna |
Osaka General Medical Center
Department of Gastroenterology and Hepatology
3-1-56 Bandaihigashi, Sumiyoshiku, Osaka
06-6692-1201
1st name | |
Middle name | |
Last name |
Osaka General Medical Center
IRB
chiken@gh.opho.jp
Osaka General Medical Center
Osaka General Medical Center
Other
NO
2012 | Year | 04 | Month | 28 | Day |
Unpublished
Enrolling by invitation
2012 | Year | 02 | Month | 15 | Day |
2012 | Year | 05 | Month | 01 | Day |
2012 | Year | 04 | Month | 28 | Day |
2012 | Year | 04 | Month | 28 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009140